PTGS2 and urinary bladder carcinoma: Previous studies also explored the use of COX-2 inhibitors on reversal EMT and tumour growth inhibition in bladder cancer, but only one of three drugs tested demonstrated the desired anti-cancer effects.81 Thus, low-dose aspirin in combination with doxorubicin may promote anti-cancer properties via multiple processes dependent and independent of the COX pathway.